Intra-gastric balloon, an aid for weight reduction in an obese patient
AbstractBackground: To evaluate safety, tolerability, and efficacy of MedSil intragastric balloon for patients with class one and two obesity.
Methods: From January 2015 to January 2017, MedSil intragastric balloons were inserted in stomachs of 85 patients. All the patients had a body mass index between 30 to 39 kg/m2 and were within the age range of 17-50. There were 55 female and 30 male, the patients underwent consent, pre balloon insertion investigations and anesthesia evaluation. The balloon was inserted via an upper endoscopy after diagnostic study; it was filled with 550-600 milliliters of methylene blue stained saline. All patients' were received analgesic and antiemetic for a week and proton pump inhibitors for 6 months after the procedure, the patients followed a program protocol included diet and exercise. The balloon was removed after 6 months. The patients were followed during the period of insertion and 6 months after the retrieval of the balloon. The weight reduction and complications were reported.
Results: Satisfactory weight loss was obtained in 85% of patients after 6 months and 75% after 12 months from insertion respectively. One patient underwent early removal of the balloon; other patient had balloon leak which necessitated replacement. Early postoperative pain and vomiting were universal but subsided in 90% during the first 10 days.
Conclusion: The intragastric balloon can be effective to achieve weight loss with low complications in stage one and two obesity.
- Article View: 3
- PDF Download: 0